The body-on-a-chip concept: possibilities and limitations

Recently, Frey et al. (2014) have established a reconfigurable microfluidic platform to study multi-tissue interactions. This platform contains multiple spheroids of different cell types in hanging drops. The hanging drops are connected by microfluidic networks. The path of the liquid flow through the hanging drops is precisely controlled and offers the possibility to perfuse them either sequently or parallelized. For example culture media may first pass a hanging drop with a liver spheroid and subsequently pass kidney, heart, bone marrow, or neu-ronal tissues (Frey et al., 2014). Currently, many groups work on the optimization of 'body-on-a-chip' systems (Kelm and Marchan, 2014; Sung et al., 2014; Williamson et al., 2013). Currently, 'organ-on-a-chip' concepts are developed for many tissues including heart (Zwei-gerdt et al. Years before the 'body-on-a-chip movement' much work has been invested in the optimization of three dimensional culture systems (Xie et al. Among the easiest and most efficient methods of 3D culture are the collagen sandwich technique, where cells are cultivated between two layers of soft gel collagen (Schug et al., 2008; 2013; O'Brien, 2006) or cell spheroids which can be generated by hanging drop cultures (Messner et al., 2013; Godoy et al., 2013). Today organo-typical in vitro systems are frequently used to study mechanisms of toxicity, particularly in the fields of hepatotoxicity (Schyschka et al. Krug et al., 2013a, b). These organotypical in vitro systems are now used in 'body-on-a-chip' devices if they can be transferred to cell culture microdevices. Nevertheless, despite of recent progress in 'body-on-a-chip' research it is clear that this concept is still in its infancy. For example, the overall quality of the 'body-on-a-chip' is limited by the quality of its 'microorgans'. Although multiple publications claim that three dimensional (3D) culture systems represent higher levels of tissue organization, this is certainly not correct. Correct would be that 3D culture systems represent some aspects of real tissue but many tissue functions are not represented. For example liver microtissues establish bile cana-liculi between the hepatocytes. Therefore, these model systems may be used to study excre-tion of compounds from hepatocytes into bile canaliculi. However, liver microtissues currently do not establish sinusoids, the liver's microvessels (Hammad et al., 2014). This causes numerous differences to real liver tissue. For example the sinusoidal tissue unit is not correctly established. Liver sinusoidal endothelial cells (LSECs) with Kupffer cells at their luminal and stellate cells at the parenchymal side are responsible for numerous …

[1]  J. Kelm,et al.  Multi-cell type human liver microtissues for hepatotoxicity testing , 2012, Archives of Toxicology.

[2]  Adam S. Hayward,et al.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME , 2013, Archives of Toxicology.

[3]  P. Bernardi,et al.  High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.

[4]  G. Damm,et al.  Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity , 2013, Archives of Toxicology.

[5]  M. L. Marquette,et al.  A novel in vitro three-dimensional skeletal muscle model , 2007, In Vitro Cellular & Developmental Biology - Animal.

[6]  Justin M. Weis,et al.  Lung-on-a-chip microdevice, right ventricular dysfunction as a predictor of survival, and lung ultrasound in community-acquired pneumonia. , 2013, American journal of respiratory and critical care medicine.

[7]  Michael R. Berthold,et al.  From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects , 2014, Archives of Toxicology.

[8]  Cheng-Hsien Liu,et al.  A biologically inspired lung-on-a-chip device for the study of protein-induced lung inflammation. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[9]  E. Lock,et al.  Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model , 2011, Archives of Toxicology.

[10]  I. Ilkavets A special issue about hepatotoxicity and hepatocyte in vitro systems , 2013, Archives of Toxicology.

[11]  B. Herpers,et al.  A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies , 2014, Archives of Toxicology.

[12]  Jiajie Yu,et al.  On chip porous polymer membranes for integration of gastrointestinal tract epithelium with microfluidic ‘body-on-a-chip’ devices , 2012, Biomedical microdevices.

[13]  T. Vanhaecke,et al.  Simple and quick method for whole-liver decellularization: a novel in vitro three-dimensional bioengineering tool? , 2011, Archives of Toxicology.

[14]  Andreas Hierlemann,et al.  Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis , 2014, Nature Communications.

[15]  Robert Zweigerdt,et al.  Your heart on a chip: iPSC-based modeling of Barth-syndrome-associated cardiomyopathy. , 2014, Cell stem cell.

[16]  Jan G. Hengstler,et al.  Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes , 2012, Archives of Toxicology.

[17]  Hedi Peterson,et al.  Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach , 2012, Archives of Toxicology.

[18]  I. Wilson,et al.  In vitro exploration of potential mechanisms of toxicity of the human hepatotoxic drug fenclozic acid , 2013, Archives of Toxicology.

[19]  Josue A. Goss,et al.  Microfluidic heart on a chip for higher throughput pharmacological studies. , 2013, Lab on a chip.

[20]  H. Bolt Developmental neurotoxicity testing with human embryonic stem cell-derived in vitro systems: the novel FP7 ESNATS tests are available , 2012, Archives of Toxicology.

[21]  J. Hengstler,et al.  Toxicokinetics of acrylamide in primary rat hepatocytes: coupling to glutathione is faster than conversion to glycidamide , 2013, Archives of Toxicology.

[22]  D. Ingber,et al.  Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[23]  Paul Jennings,et al.  Oxidative stress induced by potassium bromate exposure results in altered tight junction protein expression in renal proximal tubule cells , 2012, Archives of Toxicology.

[24]  Jong Hwan Sung,et al.  Using physiologically-based pharmacokinetic-guided “body-on-a-chip” systems to predict mammalian response to drug and chemical exposure , 2014, Experimental biology and medicine.

[25]  J. G. Hengstler,et al.  Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery , 2014, Archives of Toxicology.

[26]  M. Stern,et al.  Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity , 2013, Archives of Toxicology.

[27]  J. Kelm,et al.  Progress in ‘body-on-a-chip’ research , 2014, Archives of Toxicology.

[28]  Sukhdeep Singh,et al.  The future of the patient-specific Body-on-a-chip. , 2013, Lab on a chip.

[29]  Jan Böttger,et al.  Protocols for staining of bile canalicular and sinusoidal networks of human, mouse and pig livers, three-dimensional reconstruction and quantification of tissue microarchitecture by image processing and analysis , 2014, Archives of Toxicology.

[30]  Dorit Merhof,et al.  Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants , 2013, Archives of Toxicology.

[31]  Kerong Dai,et al.  Three-dimensional flow perfusion culture system for stem cell proliferation inside the critical-size beta-tricalcium phosphate scaffold. , 2006, Tissue engineering.

[32]  Daniel C Leslie,et al.  A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice , 2012, Science Translational Medicine.

[33]  Mandy B. Esch,et al.  Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury. , 2014, Lab on a chip.

[34]  J. Hengstler,et al.  Primary rat hepatocytes as in vitro system for gene expression studies: comparison of sandwich, Matrigel and 2D cultures , 2008, Archives of Toxicology.

[35]  T. Szekeres,et al.  Inhibition of tumour spheroid-induced prometastatic intravasation gates in the lymph endothelial cell barrier by carbamazepine: drug testing in a 3D model , 2013, Archives of Toxicology.